Finance Watch: Summit Raises $500m For Shift From Anti-Infectives To Oncology

Proceeds Will Repay Debt, Fund Phase III Trials

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.